TAGC Case Study | Invest Victoria
July 14, 2022
Genomics-driven personalised care presents an incredible opportunity to transform patient outcomes and create substantial efficiencies for the healthcare system. With support from Invest Victoria, Illumina and University of Melbourne established The Advanced Genomics Collaboration (TAGC)—presenting an incredible opportunity to transform patient outcomes and create substantial efficiencies for the healthcare system through genomics-driven personalised care. Read and watch more: https://www.invest.vic.gov.au/resources/case-studies-search/case-studies/illumina-case-study/
TAGC Panel Discussion
March 8, 2022
What is The Advanced Genomics Collaboration and why has it been established? Paul Cross, editor of Pharma Dispatch, spoke to Professor Jim McClusky, Deputy Vice-Chancellor (Research), The University of Melbourne, Tom Berkovits Sr Director, Marketing, Illumina, and Danni Jarrett, CEO Invest Victoria, about the opportunities presented by bringing together academic and industry experts in genomics.
We use genomics to improve healthcare for everyone.